 Liudmila Kulik
Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Complement 3d | 13 | 2017 | 130 | 1.930 |
Why?
| | Immunoglobulin M | 17 | 2023 | 251 | 1.860 |
Why?
| | Antibodies, Monoclonal | 10 | 2023 | 1268 | 1.400 |
Why?
| | Complement C3d | 5 | 2023 | 60 | 1.160 |
Why?
| | B-Lymphocytes | 12 | 2017 | 772 | 0.870 |
Why?
| | Reperfusion Injury | 7 | 2021 | 254 | 0.820 |
Why?
| | Receptors, Complement 3b | 4 | 2020 | 81 | 0.810 |
Why?
| | Glutamic Acid | 1 | 2023 | 211 | 0.760 |
Why?
| | Complement Activation | 11 | 2020 | 340 | 0.720 |
Why?
| | Epitopes | 9 | 2023 | 436 | 0.690 |
Why?
| | Antigen-Antibody Complex | 1 | 2019 | 88 | 0.670 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2019 | 221 | 0.570 |
Why?
| | Immune System Diseases | 1 | 2015 | 34 | 0.490 |
Why?
| | Kidney Glomerulus | 4 | 2021 | 100 | 0.470 |
Why?
| | Arthritis, Experimental | 5 | 2020 | 132 | 0.470 |
Why?
| | Mice | 30 | 2023 | 14927 | 0.450 |
Why?
| | Autoantibodies | 7 | 2019 | 1354 | 0.410 |
Why?
| | Mice, Knockout | 15 | 2019 | 2585 | 0.380 |
Why?
| | Animals | 35 | 2023 | 31867 | 0.380 |
Why?
| | Kidney Diseases | 3 | 2023 | 350 | 0.370 |
Why?
| | Annexin A4 | 2 | 2015 | 5 | 0.360 |
Why?
| | Models, Immunological | 1 | 2011 | 92 | 0.360 |
Why?
| | Antibody Formation | 3 | 2010 | 267 | 0.350 |
Why?
| | Complement C3 | 7 | 2021 | 189 | 0.350 |
Why?
| | Mice, Inbred C57BL | 17 | 2020 | 4718 | 0.340 |
Why?
| | Glomerulonephritis | 2 | 2023 | 45 | 0.330 |
Why?
| | Immunity, Innate | 4 | 2015 | 723 | 0.320 |
Why?
| | Single-Chain Antibodies | 2 | 2020 | 14 | 0.310 |
Why?
| | Glomerulosclerosis, Focal Segmental | 2 | 2021 | 29 | 0.300 |
Why?
| | Complement System Proteins | 2 | 2021 | 285 | 0.270 |
Why?
| | Antibodies | 2 | 2017 | 372 | 0.260 |
Why?
| | Complement Factor H | 2 | 2018 | 60 | 0.260 |
Why?
| | Intestinal Mucosa | 1 | 2009 | 528 | 0.230 |
Why?
| | Sheep | 5 | 2015 | 764 | 0.220 |
Why?
| | Cell Differentiation | 3 | 2007 | 1700 | 0.220 |
Why?
| | Receptors, Antigen, B-Cell | 3 | 2011 | 107 | 0.220 |
Why?
| | Annexins | 1 | 2023 | 3 | 0.220 |
Why?
| | Racemethionine | 1 | 2023 | 3 | 0.220 |
Why?
| | Receptors, Complement | 3 | 2022 | 111 | 0.220 |
Why?
| | Immunity, Humoral | 2 | 2015 | 112 | 0.220 |
Why?
| | Complement C3b | 1 | 2023 | 30 | 0.220 |
Why?
| | Antibody Specificity | 4 | 2021 | 176 | 0.210 |
Why?
| | Protein Multimerization | 2 | 2021 | 160 | 0.210 |
Why?
| | Erythrocytes | 4 | 2015 | 591 | 0.210 |
Why?
| | Immunoglobulin G | 4 | 2023 | 776 | 0.210 |
Why?
| | Antigens, CD19 | 2 | 2015 | 91 | 0.210 |
Why?
| | Foot-and-Mouth Disease | 1 | 2022 | 1 | 0.210 |
Why?
| | Foot-and-Mouth Disease Virus | 1 | 2022 | 1 | 0.210 |
Why?
| | Methionine | 1 | 2023 | 145 | 0.210 |
Why?
| | Disease Models, Animal | 5 | 2019 | 3545 | 0.200 |
Why?
| | Complement Pathway, Classical | 1 | 2021 | 19 | 0.190 |
Why?
| | Nephrosis, Lipoid | 1 | 2021 | 10 | 0.190 |
Why?
| | Nephrotic Syndrome | 1 | 2021 | 24 | 0.190 |
Why?
| | Lymphocyte Activation | 4 | 2021 | 1042 | 0.190 |
Why?
| | Cardiolipins | 1 | 2021 | 71 | 0.190 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.180 |
Why?
| | Synoviocytes | 1 | 2020 | 10 | 0.180 |
Why?
| | Protein Processing, Post-Translational | 1 | 2023 | 399 | 0.180 |
Why?
| | Autoimmunity | 3 | 2019 | 818 | 0.180 |
Why?
| | Complement Inactivating Agents | 2 | 2021 | 41 | 0.180 |
Why?
| | Joints | 1 | 2020 | 84 | 0.170 |
Why?
| | Mice, Inbred MRL lpr | 1 | 2019 | 37 | 0.170 |
Why?
| | Single Photon Emission Computed Tomography Computed Tomography | 1 | 2019 | 10 | 0.170 |
Why?
| | Mice, Transgenic | 6 | 2011 | 1955 | 0.170 |
Why?
| | Iodine Radioisotopes | 1 | 2019 | 126 | 0.160 |
Why?
| | Protein Binding | 3 | 2019 | 1898 | 0.160 |
Why?
| | Lung Transplantation | 1 | 2021 | 246 | 0.160 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2019 | 170 | 0.160 |
Why?
| | Kidney | 3 | 2023 | 1186 | 0.160 |
Why?
| | Cattle | 3 | 2022 | 924 | 0.160 |
Why?
| | Lung Injury | 1 | 2021 | 198 | 0.160 |
Why?
| | Mice, Inbred DBA | 4 | 2020 | 173 | 0.150 |
Why?
| | Clonal Anergy | 2 | 2011 | 54 | 0.150 |
Why?
| | Antirheumatic Agents | 1 | 2020 | 255 | 0.150 |
Why?
| | Complement C4b-Binding Protein | 1 | 2017 | 3 | 0.150 |
Why?
| | Tetanus Toxin | 1 | 2017 | 5 | 0.150 |
Why?
| | Ligands | 1 | 2019 | 565 | 0.150 |
Why?
| | B-Lymphocyte Subsets | 2 | 2010 | 68 | 0.150 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 125 | 0.140 |
Why?
| | Inflammation Mediators | 1 | 2019 | 476 | 0.140 |
Why?
| | Models, Molecular | 1 | 2021 | 1379 | 0.140 |
Why?
| | Tuberculosis | 1 | 2019 | 241 | 0.130 |
Why?
| | Complement Pathway, Alternative | 2 | 2018 | 114 | 0.130 |
Why?
| | Endothelial Cells | 1 | 2021 | 685 | 0.130 |
Why?
| | Mycobacterium tuberculosis | 1 | 2019 | 268 | 0.130 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 81 | 0.130 |
Why?
| | Antigens | 2 | 2015 | 318 | 0.130 |
Why?
| | Phospholipids | 2 | 2015 | 199 | 0.120 |
Why?
| | Immunoglobulin D | 1 | 2015 | 27 | 0.120 |
Why?
| | Self Tolerance | 1 | 2015 | 28 | 0.120 |
Why?
| | Humans | 19 | 2023 | 115038 | 0.120 |
Why?
| | Myocardial Reperfusion | 1 | 2015 | 49 | 0.120 |
Why?
| | Antibodies, Bispecific | 1 | 2015 | 32 | 0.120 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2015 | 91 | 0.120 |
Why?
| | Spinal Cord Injuries | 1 | 2017 | 173 | 0.120 |
Why?
| | Lymphocyte Depletion | 2 | 2013 | 116 | 0.120 |
Why?
| | Down-Regulation | 2 | 2015 | 599 | 0.120 |
Why?
| | Peptide Fragments | 1 | 2017 | 668 | 0.110 |
Why?
| | Cell Death | 1 | 2015 | 324 | 0.110 |
Why?
| | Complement C1q | 1 | 2013 | 38 | 0.110 |
Why?
| | Immunosuppressive Agents | 2 | 2021 | 651 | 0.110 |
Why?
| | Complement Pathway, Mannose-Binding Lectin | 1 | 2013 | 26 | 0.110 |
Why?
| | Craniocerebral Trauma | 1 | 2014 | 128 | 0.100 |
Why?
| | Retinal Pigment Epithelium | 1 | 2013 | 58 | 0.100 |
Why?
| | Genes, RAG-1 | 1 | 2012 | 11 | 0.100 |
Why?
| | Cytokines | 1 | 2019 | 1843 | 0.100 |
Why?
| | Head Injuries, Closed | 1 | 2012 | 47 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 390 | 0.100 |
Why?
| | Biomarkers | 2 | 2019 | 3419 | 0.100 |
Why?
| | Female | 9 | 2023 | 59610 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2018 | 638 | 0.100 |
Why?
| | Amidines | 1 | 2011 | 16 | 0.090 |
Why?
| | Chromosomes, Artificial, Bacterial | 1 | 2011 | 18 | 0.090 |
Why?
| | Ornithine | 1 | 2011 | 21 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2023 | 1153 | 0.090 |
Why?
| | Peritoneum | 1 | 2011 | 36 | 0.090 |
Why?
| | Adaptive Immunity | 1 | 2012 | 156 | 0.090 |
Why?
| | Lymphocyte Count | 1 | 2011 | 133 | 0.090 |
Why?
| | Hydrolases | 1 | 2011 | 51 | 0.090 |
Why?
| | Injections | 1 | 2011 | 159 | 0.090 |
Why?
| | Transgenes | 1 | 2011 | 170 | 0.090 |
Why?
| | Germinal Center | 3 | 2022 | 49 | 0.090 |
Why?
| | Graft Rejection | 1 | 2013 | 522 | 0.090 |
Why?
| | Chronic Disease | 1 | 2015 | 1591 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2015 | 669 | 0.080 |
Why?
| | Peptides, Cyclic | 2 | 2011 | 254 | 0.080 |
Why?
| | Inflammation | 2 | 2016 | 2485 | 0.080 |
Why?
| | Brain Ischemia | 1 | 2011 | 297 | 0.080 |
Why?
| | Doxorubicin | 2 | 2023 | 285 | 0.070 |
Why?
| | Enzyme Inhibitors | 1 | 2011 | 752 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 549 | 0.070 |
Why?
| | Lymphoid Tissue | 1 | 2007 | 62 | 0.070 |
Why?
| | Dendritic Cells, Follicular | 2 | 2022 | 5 | 0.070 |
Why?
| | Male | 12 | 2021 | 55729 | 0.070 |
Why?
| | Oxidative Stress | 1 | 2013 | 1085 | 0.070 |
Why?
| | Extracellular Space | 1 | 2007 | 117 | 0.070 |
Why?
| | Rats | 1 | 2015 | 4973 | 0.070 |
Why?
| | Homeodomain Proteins | 3 | 2015 | 464 | 0.070 |
Why?
| | Signal Transduction | 2 | 2011 | 4525 | 0.070 |
Why?
| | Cell Line | 3 | 2017 | 2645 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 2 | 2020 | 616 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2009 | 1990 | 0.060 |
Why?
| | Interferon-alpha | 1 | 2006 | 186 | 0.060 |
Why?
| | Organ Specificity | 2 | 2016 | 270 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2021 | 1237 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2796 | 0.060 |
Why?
| | Stroke | 1 | 2011 | 1015 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2379 | 0.050 |
Why?
| | Adjuvants, Immunologic | 2 | 2017 | 206 | 0.050 |
Why?
| | T-Lymphocytes | 2 | 2012 | 1747 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 2715 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 2 | 2011 | 1002 | 0.050 |
Why?
| | Capsid Proteins | 1 | 2022 | 69 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 2 | 2012 | 119 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 102 | 0.050 |
Why?
| | Proteolysis | 1 | 2021 | 143 | 0.050 |
Why?
| | Stem Cells | 1 | 2005 | 546 | 0.050 |
Why?
| | Thymocytes | 1 | 2020 | 28 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 503 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 221 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 89 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2021 | 201 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 334 | 0.040 |
Why?
| | DNA | 1 | 2006 | 1352 | 0.040 |
Why?
| | Spleen | 2 | 2013 | 486 | 0.040 |
Why?
| | Aging | 1 | 2009 | 1624 | 0.040 |
Why?
| | Tissue Distribution | 1 | 2019 | 286 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 522 | 0.040 |
Why?
| | Blotting, Western | 2 | 2012 | 1149 | 0.040 |
Why?
| | Protein Conformation | 1 | 2021 | 811 | 0.040 |
Why?
| | Synovial Membrane | 2 | 2011 | 75 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 3896 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1634 | 0.040 |
Why?
| | Apoptosis | 2 | 2020 | 2366 | 0.030 |
Why?
| | Locomotion | 1 | 2017 | 81 | 0.030 |
Why?
| | Time Factors | 3 | 2015 | 6141 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 348 | 0.030 |
Why?
| | Genes, Synthetic | 1 | 2015 | 14 | 0.030 |
Why?
| | Transplantation Tolerance | 1 | 2015 | 31 | 0.030 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2014 | 30 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3015 | 0.030 |
Why?
| | Albuminuria | 1 | 2015 | 164 | 0.030 |
Why?
| | fas Receptor | 1 | 2014 | 92 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2016 | 290 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 347 | 0.030 |
Why?
| | Complement C3-C5 Convertases | 1 | 2013 | 19 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 213 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2013 | 81 | 0.030 |
Why?
| | Choroidal Neovascularization | 1 | 2013 | 44 | 0.030 |
Why?
| | Astrocytes | 1 | 2014 | 162 | 0.030 |
Why?
| | Oxidants | 1 | 2013 | 112 | 0.030 |
Why?
| | Microglia | 1 | 2014 | 202 | 0.030 |
Why?
| | Rituximab | 1 | 2013 | 150 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2013 | 287 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2012 | 106 | 0.020 |
Why?
| | Protein-Arginine Deiminases | 1 | 2011 | 16 | 0.020 |
Why?
| | Collagen Type II | 1 | 2011 | 48 | 0.020 |
Why?
| | Citrulline | 1 | 2011 | 39 | 0.020 |
Why?
| | Myocardium | 1 | 2015 | 922 | 0.020 |
Why?
| | Vaccination | 1 | 2017 | 1205 | 0.020 |
Why?
| | Lymphocyte Subsets | 1 | 2009 | 79 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 398 | 0.020 |
Why?
| | Immunoglobulins | 1 | 2009 | 143 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2389 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 267 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 9122 | 0.020 |
Why?
| | Immune System | 1 | 2009 | 172 | 0.020 |
Why?
| | Species Specificity | 1 | 2009 | 548 | 0.020 |
Why?
| | Receptors, HIV | 1 | 2007 | 23 | 0.020 |
Why?
| | Binding Sites, Antibody | 1 | 2007 | 36 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 32 | 0.020 |
Why?
| | K562 Cells | 1 | 2007 | 73 | 0.020 |
Why?
| | Lymphopenia | 1 | 2007 | 50 | 0.020 |
Why?
| | Virion | 1 | 2007 | 73 | 0.020 |
Why?
| | Lung | 1 | 2019 | 3595 | 0.020 |
Why?
| | Lupus Vulgaris | 1 | 2006 | 4 | 0.020 |
Why?
| | Neurons | 1 | 2014 | 1284 | 0.020 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 50 | 0.020 |
Why?
| | Young Adult | 1 | 2021 | 10498 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 556 | 0.020 |
Why?
| | HIV | 1 | 2007 | 208 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2009 | 394 | 0.020 |
Why?
| | Fibrinogen | 1 | 2006 | 155 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2005 | 91 | 0.020 |
Why?
| | Collagen | 1 | 2006 | 416 | 0.010 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2005 | 353 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19119 | 0.010 |
Why?
| | Erythrocyte Transfusion | 1 | 2005 | 186 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2551 | 0.010 |
Why?
| | Leukotriene B4 | 1 | 2002 | 48 | 0.010 |
Why?
| | Up-Regulation | 1 | 2005 | 812 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2005 | 817 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 26826 | 0.010 |
Why?
| | Phenotype | 1 | 2009 | 2815 | 0.010 |
Why?
| | Adult | 1 | 2021 | 30654 | 0.010 |
Why?
| | Intestines | 1 | 2002 | 322 | 0.010 |
Why?
| | HIV Infections | 1 | 2007 | 2470 | 0.010 |
Why?
|
|
Kulik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|